Juergen Wolf

Juergen Wolf

UNVERIFIED PROFILE

Are you Juergen Wolf?   Register this Author

Register author
Juergen Wolf

Juergen Wolf

Publications by authors named "Juergen Wolf"

Are you Juergen Wolf?   Register this Author

25Publications

1127Reads

47Profile Views

Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors.

J Mol Diagn 2019 Nov 2;21(6):971-984. Epub 2019 Aug 2.

Institute of Pathology, University Hospital Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.06.006DOI Listing
November 2019

Early Palliative Care: Pro, but Please Be Precise!

Oncol Res Treat 2019 26;42(1-2):11-18. Epub 2019 Jan 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496184DOI Listing
August 2019

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer.

J Thorac Oncol 2019 May 11;14(5):768-783. Epub 2019 Feb 11.

Center for Integrated Oncology Köln Bonn, University Clinic Köln, Köln, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864193009
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2019.01.022DOI Listing
May 2019

Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.

Strahlenther Onkol 2018 02 15;194(2):91-97. Epub 2017 Aug 15.

Department of Radiation Oncology, Center for Integrated Oncology, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-017-1194-xDOI Listing
February 2018

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy.

Lancet Respir Med 2014 Dec 19;2(12):966-8. Epub 2014 Nov 19.

Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology/Oncology; University of California Irvine School of Medicine, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(14)70259-0DOI Listing
December 2014

Ceritinib in ALK-rearranged non-small-cell lung cancer.

N Engl J Med 2014 Mar;370(13):1189-97

From Massachusetts General Hospital, Boston (A.T.S., J.A.E.); Seoul National University Hospital, Seoul, South Korea (D.-W.K.); Fox Chase Cancer Center, Philadelphia (R.M.); National Cancer Center and Genome Institute of Singapore, Singapore (D.S.W.T.); Vall d'Hebron University, Barcelona (E.F.); University of Washington, Seattle (L.Q.M.C.); University of Colorado, Denver (D.R.C.); University Hospital KU Leuven, Leuven, Belgium (J.V.); Huntsman Cancer Institute, Salt Lake City (S.S.); Istituto Europeo di Oncologia (T.D.P.) and Istituto di Ricovero e Cura a Carattere Scientifico Istituto Clinico Humanitas (A.S.) - both in Milan; Memorial Sloan-Kettering Cancer Center, New York (G.J.R.); Peter MacCallum Cancer Center, Melbourne, VIC, Australia (B.J.S.); Center for Integrated Oncology, University Hospital Cologne, Cologne (J.W.), Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg, German Center for Lung Research (M.T.), and German Cancer Consortium (M.S.), Heidelberg, and University Duisburg-Essen, Essen (M.S.) - all in Germany; Princess Margaret Cancer Center, Toronto (G.L.); and Novartis Institutes for BioMedical Research, Cambridge, MA (Y.Y.L., M.G., A.L.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079055PMC
March 2014

Activated RET and ROS: two new driver mutations in lung adenocarcinoma.

Transl Lung Cancer Res 2013 Apr;2(2):112-21

Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany ; ; Center for Integrated Oncology Cologne/Bonn, Germany ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2013.03.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369857PMC
April 2013

Recommending early integration of palliative care - does it work?

Support Care Cancer 2012 Mar 19;20(3):507-13. Epub 2011 Feb 19.

Department of Palliative Medicine, University Hospital, Kerpener Strasse 62, 50937 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-011-1111-2DOI Listing
March 2012

Standardizing integration of palliative care into comprehensive cancer therapy--a disease specific approach.

Support Care Cancer 2011 Jul 24;19(7):1037-43. Epub 2011 Mar 24.

Department of Palliative Medicine, University Hospital of Cologne, 50924, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-011-1131-yDOI Listing
July 2011

Specifying WHO recommendation: moving toward disease-specific guidelines.

J Palliat Med 2010 Oct;13(10):1273-6

Department of Palliative Medicine, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2010.0016DOI Listing
October 2010

Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.

Hum Psychopharmacol 2010 Mar;25(2):126-32

Department of Psychiatry and Psychotherapy, Charité-University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.1096DOI Listing
March 2010

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

J Clin Oncol 2003 Sep 7;21(18):3440-6. Epub 2003 Mar 7.

First Department of Internal Medicine, University Hospital Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.07.160DOI Listing
September 2003